LUMAKRAS

LUMAKRAS and Vectibix Phase 3 Trial Results

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

Staff Reporter October 23, 2023 0

Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses of LUMAKRAS® (sotorasib) (960 mg or...

Amgen CodeBreaK 101 Study Results

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC

Staff Reporter September 11, 2023 0

Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study...

KW Delhi-6 Mall Joined Hands with Yashoda Healthcare to Spread Awareness on Breast Cancer

Staff Reporter November 7, 2024 0

India’s reputation as the “Pharmacy to the World” is Potentially Under Threat Substandard Imports of IPA add to the Quality Burden

Staff Reporter September 25, 2024 0

Dr. Vivek Kumar, Senior Consulting Cosmetic & Plastic Surgeon at Sculpt Clinics, Delhi, India, smiling.

Sculpt Clinics Introduces New Laser Hair Removal Technology

Staff Reporter September 6, 2024 0

HEAL Foundation Announces Healthcare CSR Summit & Awards in New Delhi

Staff Reporter August 22, 2024 0

Apsara Ice Creams Muskaan Initiative 53rd Anniversary Celebration

Apsara Ice Creams to launch Muskaan initiative on its 53rd anniversary

Staff Reporter August 16, 2024 0